Literature DB >> 11707574

A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice.

M A Farmer1, J P Sundberg, I J Bristol, G A Churchill, R Li, C O Elson, E H Leiter.   

Abstract

Colitic lesions are much more severe in C3H/HeJBir (C3H) than C57BL/6J (B6) mice after 10 backcrosses of a disrupted interleukin-10 (Il10) gene. This study identified cytokine deficiency-induced colitis susceptibility (Cdcs) modifiers by using quantitative trait locus (QTL) analysis. A segregating F(2) population (n = 408) of IL-10-deficient mice was genotyped and necropsied at 6 weeks of age. A major C3H-derived colitogenic QTL (Cdcs1) on chromosome (Chr.) 3 contributed to lesions in both cecum [logarithm of odds ratio (LOD) = 14.6)] and colon (LOD = 26.5) as well as colitis-related phenotypes such as spleen/body weight ratio, mesenteric lymph node/body weight ratio, and secretory IgA levels. Evidence for other C3H QTL on Chr. 1 (Cdcs2) and Chr. 2 (Cdcs3) was obtained. Cdcs1 interacted epistatically or contributed additively with loci on other chromosomes. The resistant B6 background also contributed colitogenic QTL: Cdcs4 (Chr. 8), Cdcs5 (Chr. 17, MHC), and Cdcs6 (Chr. 18). Epistatic interactions between B6 QTL on Chr. 8 and 18 contributing to cecum hyperplasia were particularly striking. In conclusion, a colitogenic susceptibility QTL on Chr. 3 has been shown to exacerbate colitis in combination with modifiers contributed from both parental genomes. The complex nature of interactions among loci in this mouse model system, coupled with separate deleterious contributions from both parental strains, illustrates why detection of human inflammatory bowel disease linkages has proven to be so difficult. A human ortholog of the Chr. 3 QTL, if one exists, would map to Chr. 4q or 1p.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707574      PMCID: PMC61125          DOI: 10.1073/pnas.241258698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  A statistical framework for quantitative trait mapping.

Authors:  S Sen; G A Churchill
Journal:  Genetics       Date:  2001-09       Impact factor: 4.562

2.  Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci.

Authors:  J D Rioux; M S Silverberg; M J Daly; A H Steinhart; R S McLeod; A M Griffiths; T Green; T S Brettin; V Stone; S B Bull; A Bitton; C N Williams; G R Greenberg; Z Cohen; E S Lander; T J Hudson; K A Siminovitch
Journal:  Am J Hum Genet       Date:  2000-04-21       Impact factor: 11.025

3.  Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci.

Authors:  F Sugiyama; G A Churchill; D C Higgins; C Johns; K P Makaritsis; H Gavras; B Paigen
Journal:  Genomics       Date:  2001-01-01       Impact factor: 5.736

4.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.

Authors:  C Tysk; E Lindberg; G Järnerot; B Flodérus-Myrhed
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

5.  The sole gateway to endotoxin response: how LPS was identified as Tlr4, and its role in innate immunity.

Authors:  B Beutler; A Poltorak
Journal:  Drug Metab Dispos       Date:  2001-04       Impact factor: 3.922

6.  A point mutation in the IL-12R beta 2 gene underlies the IL-12 unresponsiveness of Lps-defective C57BL/10ScCr mice.

Authors:  A Poltorak; T Merlin; P J Nielsen; O Sandra; I Smirnova; I Schupp; T Boehm; C Galanos; M A Freudenberg
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

7.  Heritable susceptibility for colitis in mice induced by IL-10 deficiency.

Authors:  I J Bristol; M A Farmer; Y Cong; X X Zheng; T B Strom; C O Elson; J P Sundberg; E H Leiter
Journal:  Inflamm Bowel Dis       Date:  2000-11       Impact factor: 5.325

8.  The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.

Authors:  R T Cormier; A Bilger; A J Lillich; R B Halberg; K H Hong; K A Gould; N Borenstein; E S Lander; W F Dove
Journal:  Oncogene       Date:  2000-06-29       Impact factor: 9.867

9.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

10.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

View more
  46 in total

1.  A model selection approach for expression quantitative trait loci (eQTL) mapping.

Authors:  Ping Wang; John A Dawson; Mark P Keller; Brian S Yandell; Nancy A Thornberry; Bei B Zhang; I-Ming Wang; Eric E Schadt; Alan D Attie; C Kendziorski
Journal:  Genetics       Date:  2010-11-29       Impact factor: 4.562

2.  Optical reconstruction of murine colorectal mucosa at cellular resolution.

Authors:  Cambrian Y Liu; Philip E Dubé; Nandini Girish; Ajay T Reddy; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-02-26       Impact factor: 4.052

3.  Characterisation of chloride currents across the proximal colon in CftrTgH(neoim)1Hgu congenic mice.

Authors:  E-M Bleich; S Leonhard-Marek; M Beyerbach; G Breves
Journal:  J Comp Physiol B       Date:  2006-07-26       Impact factor: 2.200

4.  Colitis locus on chromosome 2 impacting the severity of early-onset disease in mice deficient in GPX1 and GPX2.

Authors:  R Steven Esworthy; Byung-Wook Kim; Garrett P Larson; M L Richard Yip; David D Smith; Min Li; Fong-Fong Chu
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

5.  The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients.

Authors:  Tamas Szamosi; Peter Laszlo Lakatos; Aniko Szilvasi; Laszlo Lakatos; Agota Kovacs; Tamas Molnar; Istvan Altorjay; Maria Papp; Orsolya Szabo; Anna Satori; Zsolt Tulassay; Pal Miheller; Henrik Csaba Horvath; Janos Papp; Attila Tordai; Hajnalka Andrikovics
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

Review 6.  New pathophysiological insights and modern treatment of IBD.

Authors:  Matthias A Engel; Markus F Neurath
Journal:  J Gastroenterol       Date:  2010-03-09       Impact factor: 7.527

7.  Quantitative trait loci in a bacterially induced model of inflammatory bowel disease.

Authors:  Andrew E Hillhouse; Matthew H Myles; Jeremy F Taylor; Elizabeth C Bryda; Craig L Franklin
Journal:  Mamm Genome       Date:  2011-06-30       Impact factor: 2.957

8.  Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis.

Authors:  M Schnoor; A Betanzos; D A Weber; C A Parkos
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

9.  A data-capture tool for mouse pathology phenotyping.

Authors:  B A Sundberg; P N Schofield; M Gruenberger; J P Sundberg
Journal:  Vet Pathol       Date:  2009-07-15       Impact factor: 2.221

Review 10.  Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.

Authors:  Marla Dubinsky; Jonathan Braun
Journal:  Gastroenterology       Date:  2015-08-15       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.